Press Releases
Recent Press Releases
-
Tranzyme Pharma to Present Ulimorelin Data Showing Reduction in Daily Vomiting in Patients with Diabetic Gastroparesis
August 25, 2010
-
Tranzyme Pharma Announces Positive Results from Phase 2 Study of Oral TZP-102 (Ghrelin Agonist) in Patients with Diabetic Gastroparesis
June 29, 2010
-
Tranzyme Pharma and Norgine Sign License Agreement for Late-Stage Development Product, Ulimorelin (TZP-101), in Europe and Other Select Regions
June 16, 2010
-
Tranzyme Pharma Enters Into Strategic Drug Discovery Collaboration with Bristol-Myers Squibb
December 8, 2009
-
Tranzyme Pharma Receives FDA Fast Track Status for Its Oral GI Prokinetic Drug Candidate TZP-102
July 27, 2009
-
Tranzyme Pharma CEO Vipin Garg Wins Ernst & Young Entrepreneur Of The Year® Award
June 23, 2009